- Home
- QBTS vs TIL Comparison
QBTS vs TIL Comparison
Compare QBTS & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QBTS
- TIL
- Stock Information
- Founded
- QBTS 1999
- TIL 2018
- Country
- QBTS Canada
- TIL United States
- Employees
- QBTS N/A
- TIL N/A
- Industry
- QBTS Retail: Computer Software & Peripheral Equipment
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- QBTS Technology
- TIL Health Care
- Exchange
- QBTS Nasdaq
- TIL Nasdaq
- Market Cap
- QBTS 194.5M
- TIL 170.7M
- IPO Year
- QBTS N/A
- TIL 2021
- Fundamental
- Price
- QBTS $8.40
- TIL $21.69
- Analyst Decision
- QBTS Strong Buy
- TIL Buy
- Analyst Count
- QBTS 6
- TIL 4
- Target Price
- QBTS $3.71
- TIL $100.33
- AVG Volume (30 Days)
- QBTS 64.2M
- TIL 107.5K
- Earning Date
- QBTS 11-14-2024
- TIL 11-13-2024
- Dividend Yield
- QBTS N/A
- TIL N/A
- EPS Growth
- QBTS N/A
- TIL N/A
- EPS
- QBTS N/A
- TIL N/A
- Revenue
- QBTS $9,424,000.00
- TIL N/A
- Revenue This Year
- QBTS $4.82
- TIL N/A
- Revenue Next Year
- QBTS $64.23
- TIL $2.65
- P/E Ratio
- QBTS N/A
- TIL N/A
- Revenue Growth
- QBTS 14.27
- TIL N/A
- 52 Week Low
- QBTS $0.68
- TIL $6.72
- 52 Week High
- QBTS $9.42
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- QBTS 83.92
- TIL 37.92
- Support Level
- QBTS $3.71
- TIL $20.57
- Resistance Level
- QBTS $5.38
- TIL $30.64
- Average True Range (ATR)
- QBTS 1.08
- TIL 2.99
- MACD
- QBTS 0.41
- TIL -0.19
- Stochastic Oscillator
- QBTS 85.26
- TIL 11.12
About QBTS D-Wave Quantum Inc.
D-Wave Quantum Inc is engaged in the development and delivery of quantum computing systems, software, and services, and is the commercial supplier of quantum computers—and the only company building both annealing quantum computers and gate-model quantum computers. The Company's mission is to unlock the power of quantum computing today to benefit business and society. D-Wave does this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modelling. D-Wave's annealing quantum computers are accessible through the Company's LeapTM cloud service.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.